275 related articles for article (PubMed ID: 34101385)
1. Multiparametric Analyses of Hepatocellular Carcinoma Somatic Mouse Models and Their Associated Tumor Microenvironment.
Taranto D; Ramirez CFA; Vegna S; de Groot MHP; de Wit N; Van Baalen M; Klarenbeek S; Akkari L
Curr Protoc; 2021 Jun; 1(6):e147. PubMed ID: 34101385
[TBL] [Abstract][Full Text] [Related]
2. Establishment of a murine hepatocellular carcinoma model by hydrodynamic injection and characterization of the immune tumor microenvironment.
Repáraz D; Casares N; Fuentes A; Navarro F
Methods Cell Biol; 2024; 185():79-97. PubMed ID: 38556453
[TBL] [Abstract][Full Text] [Related]
3. Plasma Cell Polarization to the Immunoglobulin G Phenotype in Hepatocellular Carcinomas Involves Epigenetic Alterations and Promotes Hepatoma Progression in Mice.
Wei Y; Lao XM; Xiao X; Wang XY; Wu ZJ; Zeng QH; Wu CY; Wu RQ; Chen ZX; Zheng L; Li B; Kuang DM
Gastroenterology; 2019 May; 156(6):1890-1904.e16. PubMed ID: 30711627
[TBL] [Abstract][Full Text] [Related]
4. Erythroid-transdifferentiated myeloid cells promote portal vein tumor thrombus in hepatocellular carcinoma.
Zhu WH; Chen J; Huang RK; Zhang Y; Huang ZX; Pang XQ; Hu B; Yang Y; Li X
Theranostics; 2023; 13(13):4316-4332. PubMed ID: 37649603
[No Abstract] [Full Text] [Related]
5. Using Full-Spectrum Flow Cytometry to Phenotype Memory T and NKT Cell Subsets with Optimized Tissue-Specific Preparation Protocols.
Farrand K; Holz LE; Ferrer-Font L; Wilson MD; Ganley M; Minnell JJ; Tang CW; Painter GF; Heath WR; Hermans IF; Burn OK
Curr Protoc; 2022 Jul; 2(7):e482. PubMed ID: 35819836
[TBL] [Abstract][Full Text] [Related]
6. Cooperation Between Distinct Cancer Driver Genes Underlies Intertumor Heterogeneity in Hepatocellular Carcinoma.
Molina-Sánchez P; Ruiz de Galarreta M; Yao MA; Lindblad KE; Bresnahan E; Bitterman E; Martin TC; Rubenstein T; Nie K; Golas J; Choudhary S; Bárcena-Varela M; Elmas A; Miguela V; Ding Y; Kan Z; Grinspan LT; Huang KL; Parsons RE; Shields DJ; Rollins RA; Lujambio A
Gastroenterology; 2020 Dec; 159(6):2203-2220.e14. PubMed ID: 32814112
[TBL] [Abstract][Full Text] [Related]
7. CRISPR/Cas9 Engineering of Adult Mouse Liver Demonstrates That the Dnajb1-Prkaca Gene Fusion Is Sufficient to Induce Tumors Resembling Fibrolamellar Hepatocellular Carcinoma.
Engelholm LH; Riaz A; Serra D; Dagnæs-Hansen F; Johansen JV; Santoni-Rugiu E; Hansen SH; Niola F; Frödin M
Gastroenterology; 2017 Dec; 153(6):1662-1673.e10. PubMed ID: 28923495
[TBL] [Abstract][Full Text] [Related]
8. Acidic Microenvironment Up-Regulates Exosomal miR-21 and miR-10b in Early-Stage Hepatocellular Carcinoma to Promote Cancer Cell Proliferation and Metastasis.
Tian XP; Wang CY; Jin XH; Li M; Wang FW; Huang WJ; Yun JP; Xu RH; Cai QQ; Xie D
Theranostics; 2019; 9(7):1965-1979. PubMed ID: 31037150
[No Abstract] [Full Text] [Related]
9. Single-cell RNA sequencing revealed potential targets for immunotherapy studies in hepatocellular carcinoma.
Xie Z; Huang J; Li Y; Zhu Q; Huang X; Chen J; Wei C; Luo S; Yang S; Gao J
Sci Rep; 2023 Nov; 13(1):18799. PubMed ID: 37914817
[TBL] [Abstract][Full Text] [Related]
10. Delineation of an immunosuppressive gradient in hepatocellular carcinoma using high-dimensional proteomic and transcriptomic analyses.
Chew V; Lai L; Pan L; Lim CJ; Li J; Ong R; Chua C; Leong JY; Lim KH; Toh HC; Lee SY; Chan CY; Goh BKP; Chung A; Chow PKH; Albani S
Proc Natl Acad Sci U S A; 2017 Jul; 114(29):E5900-E5909. PubMed ID: 28674001
[TBL] [Abstract][Full Text] [Related]
11. Tumor Microenvironment of Hepatocellular Carcinoma: Challenges and Opportunities for New Treatment Options.
Sas Z; Cendrowicz E; Weinhäuser I; Rygiel TP
Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35409139
[TBL] [Abstract][Full Text] [Related]
12. A Transposon-Based Mouse Model of Hepatocellular Carcinoma via Hydrodynamic Tail Vein Injection.
Yu S; Vernia S
Methods Mol Biol; 2020; 2164():129-143. PubMed ID: 32607890
[TBL] [Abstract][Full Text] [Related]
13. Construction of a risk score prognosis model based on hepatocellular carcinoma microenvironment.
Zhang FP; Huang YP; Luo WX; Deng WY; Liu CQ; Xu LB; Liu C
World J Gastroenterol; 2020 Jan; 26(2):134-153. PubMed ID: 31969776
[TBL] [Abstract][Full Text] [Related]
14. Hepatocellular Carcinoma Cells Up-regulate PVRL1, Stabilizing PVR and Inhibiting the Cytotoxic T-Cell Response via TIGIT to Mediate Tumor Resistance to PD1 Inhibitors in Mice.
Chiu DK; Yuen VW; Cheu JW; Wei LL; Ting V; Fehlings M; Sumatoh H; Nardin A; Newell EW; Ng IO; Yau TC; Wong CM; Wong CC
Gastroenterology; 2020 Aug; 159(2):609-623. PubMed ID: 32275969
[TBL] [Abstract][Full Text] [Related]
15. A novel spontaneous hepatocellular carcinoma mouse model for studying T-cell exhaustion in the tumor microenvironment.
Liu YT; Tseng TC; Soong RS; Peng CY; Cheng YH; Huang SF; Chuang TH; Kao JH; Huang LR
J Immunother Cancer; 2018 Dec; 6(1):144. PubMed ID: 30526672
[TBL] [Abstract][Full Text] [Related]
16. Loss of SIRT5 promotes bile acid-induced immunosuppressive microenvironment and hepatocarcinogenesis.
Sun R; Zhang Z; Bao R; Guo X; Gu Y; Yang W; Wei J; Chen X; Tong L; Meng J; Zhong C; Zhang C; Zhang J; Sun Y; Ling C; Tong X; Yu FX; Yu H; Qu W; Zhao B; Guo W; Qian M; Saiyin H; Liu Y; Liu RH; Xie C; Liu W; Xiong Y; Guan KL; Shi Y; Wang P; Ye D
J Hepatol; 2022 Aug; 77(2):453-466. PubMed ID: 35292350
[TBL] [Abstract][Full Text] [Related]
17. Tumor-Associated Neutrophils Recruit Macrophages and T-Regulatory Cells to Promote Progression of Hepatocellular Carcinoma and Resistance to Sorafenib.
Zhou SL; Zhou ZJ; Hu ZQ; Huang XW; Wang Z; Chen EB; Fan J; Cao Y; Dai Z; Zhou J
Gastroenterology; 2016 Jun; 150(7):1646-1658.e17. PubMed ID: 26924089
[TBL] [Abstract][Full Text] [Related]
18. Ultrasound-mediated delivery of miRNA-122 and anti-miRNA-21 therapeutically immunomodulates murine hepatocellular carcinoma in vivo.
Wischhusen JC; Chowdhury SM; Lee T; Wang H; Bachawal S; Devulapally R; Afjei R; Sukumar UK; Paulmurugan R
J Control Release; 2020 May; 321():272-284. PubMed ID: 32004588
[TBL] [Abstract][Full Text] [Related]
19. Disruption of SIRT7 Increases the Efficacy of Checkpoint Inhibitor via MEF2D Regulation of Programmed Cell Death 1 Ligand 1 in Hepatocellular Carcinoma Cells.
Xiang J; Zhang N; Sun H; Su L; Zhang C; Xu H; Feng J; Wang M; Chen J; Liu L; Shan J; Shen J; Yang Z; Wang G; Zhou H; Prieto J; Ávila MA; Liu C; Qian C
Gastroenterology; 2020 Feb; 158(3):664-678.e24. PubMed ID: 31678303
[TBL] [Abstract][Full Text] [Related]
20. Loss of ATOH8 Increases Stem Cell Features of Hepatocellular Carcinoma Cells.
Song Y; Pan G; Chen L; Ma S; Zeng T; Man Chan TH; Li L; Lian Q; Chow R; Cai X; Li Y; Li Y; Liu M; Li Y; Zhu Y; Wong N; Yuan YF; Pei D; Guan XY
Gastroenterology; 2015 Oct; 149(4):1068-81.e5. PubMed ID: 26099525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
